Medtronic (MDT) Competitors

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, community ranking, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Which has stronger earnings and valuation, ABT or MDT?

Abbott Laboratories has higher revenue and earnings than Medtronic. Abbott Laboratories is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$41.95B	5.26	$13.40B	$7.65	16.64
Medtronic	$33.20B	3.48	$3.68B	$3.29	27.40

Is ABT or MDT more profitable?

Abbott Laboratories has a net margin of 31.95% compared to Medtronic's net margin of 12.83%. Abbott Laboratories' return on equity of 20.74% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	31.95%	20.74%	11.19%
Medtronic	12.83%	14.07%	7.70%

Does the MarketBeat Community prefer ABT or MDT?

Medtronic received 643 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.49% of users gave Medtronic an outperform vote while only 69.97% of users gave Abbott Laboratories an outperform vote.

Company	Underperform	Outperform
Abbott Laboratories	Outperform Votes 946 69.97%	Underperform Votes 406 30.03%
Medtronic	Outperform Votes 1589 75.49%	Underperform Votes 516 24.51%

Does the media favor ABT or MDT?

In the previous week, Abbott Laboratories had 4 more articles in the media than Medtronic. MarketBeat recorded 57 mentions for Abbott Laboratories and 53 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.44 beat Medtronic's score of 1.14 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	51 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	41 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Do analysts prefer ABT or MDT?

Abbott Laboratories currently has a consensus target price of $137.94, indicating a potential upside of 8.35%. Medtronic has a consensus target price of $96.07, indicating a potential upside of 6.55%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities research analysts plainly believe Abbott Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Do insiders and institutionals have more ownership in ABT or MDT?

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 1.1% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.2% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more risk & volatility, ABT or MDT?

Abbott Laboratories has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.

Is ABT or MDT a better dividend stock?

Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.1%. Abbott Laboratories pays out 30.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Medtronic has raised its dividend for 48 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Abbott Laboratories beats Medtronic on 14 of the 21 factors compared between the two stocks.